Trials / Conditions / Metastatic Hypopharyngeal Squamous Cell Carcinoma

Metastatic Hypopharyngeal Squamous Cell Carcinoma

9 registered clinical trials studyying Metastatic Hypopharyngeal Squamous Cell Carcinoma — 5 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	TMV Vaccine Therapy Alone and With Pembrolizumab for the Treatment of Recurrent and/or Metastatic Head and Nec NCT06868433	Emory University	Phase 1
Recruiting	Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returni NCT06589804	National Cancer Institute (NCI)	Phase 3
Recruiting	Remote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin a NCT06662058	Emory University	N/A
Recruiting	Lovastatin and Pembrolizumab for the Treatment of Patients With Recurrent or Metastatic Head and Neck Cancer, NCT06636734	Emory University	Phase 2
Active Not Recruiting	Combining Radiation Therapy With Immunotherapy for the Treatment of Metastatic Squamous Cell Carcinoma of the NCT05721755	ECOG-ACRIN Cancer Research Group	Phase 3
Active Not Recruiting	Testing the Use of Investigational Drugs Atezolizumab and/or Bevacizumab With or Without Standard Chemotherapy NCT05063552	National Cancer Institute (NCI)	Phase 2 / Phase 3
Recruiting	BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Mel NCT05136196	National Cancer Institute (NCI)	Phase 2
Active Not Recruiting	Testing the Addition of an Anti-cancer Drug, Ipatasertib, to the Usual Immunotherapy Treatment (Pembrolizumab) NCT05172258	National Cancer Institute (NCI)	Phase 2
Active Not Recruiting	Cemiplimab, Low-Dose Paclitaxel and Carboplatin for the Treatment of Recurrent/Metastatic Squamous Cell Carcin NCT04862650	Marcelo Bonomi	Phase 2